Continuous renal replacement therapy (CRRT) was introduced more than 40 years ago as a renal support option for critically ill patients who had contraindications to intermittent hemodialysis and peritoneal dialysis. Despite being the most common renal support therapy used in intensive care units today, the tremendous variability in CRRT management challenges the interpretation of findings from CRRT outcome studies. The lack of standardization in practice and training of clinicians along with the high risk of CRRT-related adverse events has been the impetus for the recent expert consensus work on identifying quality indicators for CRRT programs. This article summarizes the potential complications that establish CRRT as a high-risk therapy and also the recently published best-practice recommendations for providing high-quality CRRT.
Symposium Continuous Renal Replacement Therapy| March 15 2017
Continuous Renal Replacement Therapy Update: An Emphasis on Safe and High-Quality Care
Hildy Schell-Chaple, RN, PhD, CCNS
AACN Adv Crit Care (2017) 28 (1): 31–40.
- Views Icon Views
- Share Icon Share
Hildy Schell-Chaple; Continuous Renal Replacement Therapy Update: An Emphasis on Safe and High-Quality Care. AACN Adv Crit Care 15 March 2017; 28 (1): 31–40. doi: https://doi.org/10.4037/aacnacc2017816
Download citation file: